Bayforest Capital LTD Charles River Laboratories International, Inc. Transaction History
Bayforest Capital LTD
- $210 Billion
- Q3 2025
A detailed history of Bayforest Capital LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 963 shares of CRL stock, worth $161,601. This represents 0.07% of its overall portfolio holdings.
Number of Shares
963
Previous 417
130.94%
Holding current value
$161,601
Previous $63.3 Million
138.14%
% of portfolio
0.07%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
644Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...